Clinical Trial Update: Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of AL01211 in treatment-naive males with classic Fabry disease; the study is currently recruiting to evaluate safety a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• AL01211 (AL01211)

Snippet

Sponsor: AceLink Therapeutics, Inc. | Conditions: Fabry Disease | Phase 2 | Status: RECRUITING